Action MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Medical Developments International Limited

Actions

MVP

AU000000MVP2

Marché Fermé - Australian S.E.
Autres places de cotation
 08:10:44 26/04/2024 		Varia. 5j. Varia. 1 janv.
0,54 AUD -3,57% Graphique intraday de Medical Developments International Limited -4,42% -28,95%
29/02 Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024
28/02 Medical Developments International Limited annonce ses résultats pour le semestre clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Medical Developments International Limited Announces Resignation of David Williams from Board
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%
Medical Developments International Limited Discontinues China Clinical Trials
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited
Medical Developments International Limited Announces Chief Financial Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MVP
  4. Actualités Medical Developments International Limited
  5. Autres langues